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Abstract
BACKGROUND: The vascular calcification process in chronic kidney disease (CKD) is a complication caused by 
mineral and bone abnormalities and becomes the risk of cardiovascular disease and mortality in CKD patients. 
KLOTHO is an inhibitor of calcification and its expression has been observed to decrease in CKD patients. The 
KLOTHO gene G395A polymorphism is a genetic variation that is common in Asian populations and is associated 
with vascular dysfunction in hemodialysis patients.
OBJECTIVE: The objective of the study was to determine the association between the KLOTHO gene G395A 
polymorphism and carotid artery calcification in regular hemodialysis patients.
METHODS: This study was an analytical study with a cross-sectional design and was carried out at Rasyida Kidney 
Hospital Medan. Venous blood sample was taken from the patients who met the inclusion criteria for examination of 
the KLOTHO gene -395 polymorphism and carotid ultrasonography was assessed to evaluate the thickness of the 
tunica media-intima as a marker of vascular calcification.
RESULTS: The majority of the study subjects were men, as many as 35 patients (50.7%). From the results of the 
KLOTHO gene -395 polymorphism, it was found that the majority of subjects had GG genotypes as many as 36 
people (52.2%) followed by GA genotypes as many as 30 people (43,5%) and AA genotypes as many as 3 (4,3%). 
There was a statistically significant of the association between KLOTHO gene -395 polymorphism and the incidence 
of carotid artery calcification (p = 0,015).
CONCLUSION: There was an association between the KLOTHO gene G395A polymorphism and carotid artery 
calcification in regular hemodialysis patients.
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Introduction
The incidence of chronic kidney disease (CKD) 
in the world remains high and becomes a major global 
health burden. CKD can develop into end-stage renal 
disease (ESRD) which requires renal replacement 
therapy such as hemodialysis [1]. In Norway, the 
incidence of CKD is 10,2% of total population. This 
result is similar in China where the incidence is 7,2–
13,7% [2]. There are so many complications of CKD, 
one of them is a mineral abnormality in the form of 
vascular classification [3]. This situation is an important 
contributor to the incidence of cardiovascular disease 
that determines the mortality of patients with CKD [4].
In our body, there are some promoter 
and inhibitor of vascular classification to maintain 
the calcification process in vascular. KLOTHO, a 
transmembrane protein expressed in kidney, is one of 
the classified inhibitors [5]. KLOTHO gene has been 
reported to be related to bone density, coronary artery 
disease, and cardiovascular risk factors such as the 
homeostasis calcium and phosphate in the kidney. 
The defect in this gene shows the acceleration of 
vascular atherosclerosis along with classification [6]. All 
experiments to date have shown the protective effect of 
KLOTHO on the incidence of vascular classification [5]. 
Single-nucleotide polymorphisms (SNPs) are inherited 
human gene variations when a single nucleotide 
changes in the genome sequence [7]. In the KLOTHO 
gene, SNPs on G395A are very common in Asian 
populations [8]. So far, there are no data on whether 
the G395A KLOTHO gene polymorphism is related 
to carotid artery calcification in regular hemodialysis 
patients in Indonesia, so the authors are interested in 
conducting this study.
Methods
Study design
This study was an analytical research method 
with cross-sectional design in June–August 2018 
 Ahmadetal.AssociationbetweenKLOTHOGeneG395APolymorphismandCarotidArteryCalcification
Open Access Maced J Med Sci. 2020 May 13; 8(A):208-213. 209
at Rasyida Kidney Hospital, Medan. The Faculty of 
Medicine, Universitas Sumatera Utara Ethics Committee 
approved this study. The main objective of this research 
was to determine whether there was an association 
between KLOTHO gene G395A polymorphism and 
carotid artery classification in regular hemodialysis 
patients.
Selection of participants
Subjects over the age of 18, CKD patients 
who have undergone regular hemodialysis (HD) ≥3 
months, cooperative patients, and willing to participate 
by signed an informed consent form were served as 
research inclusion criteria. We determined the comorbid 
diseases, duration of hemodialysis from history taking 
and medical record, and calculated the body mass index 
(BMI). Then, the research subjects were taken a blood 
sample to evaluate the calcium and phosphate serum 
levels, the KLOTHO gene G395A polymorphisms and 
carotid ultrasonography were done to evaluate the 
carotid intima-media thickness (CIMT).
The KLOTHO gene G395A polymorphism was 
examined by polymerase chain reaction with confronting 
two-pair primers method (PCR-CTTP). In this genotyping 
of G395A in the promoter region procedure, as described 
previously by Shimoyama et al. (2009), the confronting 
pairs of primers are as follows: Forward primer 1: 
GTTTCGTGGACGCTCAGGTTCATTCTC, forward 
primer 2: GAGAAAAGGCGCCGACCAACTTTC, reverse 
primer 1: GATCCCGCCCC- CAAGTCGGGA, and 
reverse primer 2: GTCCCTCTAGGATTTCGGCCAG [9]. 
These polymorphism regions were amplified by PCR 
for 10 min with the initial denature at 95°C followed 
for 1 min at 95°C (35 cycles), for 1 min at 65°C, for 
1 min at 72°C, and additionally for 5 min at 72°C and 
the products were visualized with 3% agarose gel and 
ethidium bromide staining. The GG genotype is located 
at 252 bp (base pair) and 175 bp, the GA genotype at 
252, 175, and 121 bp, and the AA genotype at 252 and 
121 bp (Figure 1). Research subjects were also done 
the carotid ultrasonography examination to evaluate the 
carotid intima-media thickness (CIMT). CIMT is defined 
as the measurable distance between the intima lumen 
and the media-adventitia boundary [10]. A positive 
result is if the CIMT > 1 mm.
Statistical analysis
We performed the univariate, bivariate, 
and multivariate analysis. The distribution of subject 
characteristics was analyzed by univariate analysis and 
displayed as a percentage. The association between 
independent and dependent variables was analyzed 
by bivariate analysis. For categorical variables, we 
performed Chi-squared test or Fisher’s exact test as 
an alternative while numerical variables were analyzed 
by independent t-test or Mann–Whitney U-test as an 
alternative. Multivariate analysis was performed by 
regression logistic test. The significant results was 
considered if p < 0,05 (p<0,05).
Results
Characteristics of research subjects
From a total of 69 research subjects, the 
majority of subjects were men as many as 35 (50,7%) 
subjects with median age was 55 (26–78) years old. 
Hypertension was the most comorbid disease as many 
as 53 (76,8%) subjects followed by diabetes mellitus as 
many as 16 (23,3%) subjects. The normal BMI group 
was the most in this study as many as 26 (18,8%) 
subjects (Table 1).
From the KLOTHO gene G395A polymorphisms 
examination, we found that the majority of subjects had 
GG genotype as many as 36 (52,2%) subjects followed 
by GA genotype as many as 30 (43,5%) subjects and 
AA genotype as many as 3 (4,3%) subjects. Based on 
carotid ultrasonography examination, it was found that 
the majority of subjects had CIMT ≤ 1 mm, as many as 
41 (59,4%) subjects (Table 1).
Association between research subjects 
characteristics and KLOTHO gene -395 
polymorphisms with carotid artery calcification
We performed a bivariate analysis to determine 
the association of research subjects characteristics 
Figure 1: The PCR-CTTP analysis for genotype of KLOTHO gene 
G395A polymorphisms. Lanes 1, 3, and 6 indicate the GG genotype, 
lanes 2 and 4 indicate GA genotype, lane 5 indicates the AA genotype
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to the incidence of carotid artery calcification. Based 
on statistical test, hypertension as comorbid disease 
(p = 0,009) and the categories of BMI (p = 0,039) 
are associated with the incidence of carotid artery 
calcification. Both of these risk factors along with other 
risk factors that have p < 0,25, such as diabetes as 
comorbid disease and calcium levels, will be included 
in the multivariate analysis (Table 2).
We determined risk factors that influence the 
incidence of carotid artery calcification by multivariate 
analysis with logistic regression tests. The variables 
with p ≤ 0,25 in the bivariate tests such as KLOTHO 
gene -395 polymorphisms GA and AA genotypes, 
history of diabetes, history of hypertension, calcium 
levels, and BMI categories will be included in the test.
Based on this analysis, risk factors that 
influence the incidence of carotid artery calcification 
were KLOTHO gene -395 polymorphisms GA and 
AA genotype, history of diabetes, and history of 
hypertension (p = 0,002; p = 0,022; and p = 0,006) 
(Table 4). These three risk factors will increase the 
likelihood of carotid artery calcification. Based on these 
statistical tests, a formulation can be made in predicting 
the occurrence of carotid artery calcification as follows:
Possible calcification events = (−2,479) + 
(1,996 GA and AA KLOTHO gene polymorphisms) 
+ (1,829 history of diabetes) + (2,336 history of 
hypertension)
Discussion
CKD is an increasing public health problem 
where the prevalence of CKD in various regional 
countries varies with gender. Epidemiological studies 
conducted by Lebov et al. in the Pacific coastal regions 
of Nicaragua and El Salvador, in 2015, showed an 
increased in the incidence of CKD among young adult 
men and the average age of CKD occurrence is 51 
(±12) years [11]. Our study showed the similar results, 
from 69 research subjects, the majority of subjects were 
men, as many as 35 people (50.7%) with a median 
age of 55 years. Different results are shown as in the 
study of Carrero et al., in 2018, on gender differences 
in the epidemiology of CKD in some countries that the 
prevalence of CKD in the regional majority is more 
common in female as in Finland with a ratio of women to 
men which is 3,1:1,9 [12]. Testosterone has a bad effect 
on the kidneys because it induces apoptosis of podocyte 
cells which can develop into glomerulosclerosis and 
increases TGF-β1 expression associated with the 
incidence of tissue fibrosis, while estradiol inhibits this 
process. Meanwhile, decreased estrogen levels have 
been linked to decrease nitric oxide (NO) synthesis in 
the renal medulla which is generally associated with 
kidney injury [13], [14], [15].
Various etiologies that cause kidney damage 
include primary glomerulopathy, hypertension, diabetes, 
and the presence of post-renal obstruction and others. 
Data from the Indonesian Renal Registry in 2017 show 
that hypertension is still the most common comorbid 
disease in CKD patients undergoing HD in Indonesia 
as many as 36% and followed by diabetes as much as 
29% [16]. Our findings are consistent with the previous 
Table 2. Association between research subjects characteristics 
with carotid artery calcification
Risk factors Calcification No calcification p value
Sex, n (%)
Men
Women
16 (57.1)
12 (42.9)
19 (46.3)
22 (53.7)
0.378*
Diabetes, n (%)
Yes
No
9 (32.1)
19 (67.9)
7 (17.1)
34 (82.9)
0.145*
Hypertension, n (%)
Yes 
No
26 (92.9)
2 (7.1)
27 (65.9)
14 (34.1)
0.009*
BMI categories, n (%)
Overweight – obesity
Underweight – normal
20 (71.4)
8 (28.6)
19 (46.3)
22 (53.7)
0.039*
Mean calcium levels, mg/dL 39.5 31.8 0.119&
Mean phosphate levels, mg/dL 5.5 5.4 0.862^
Median of age, year (min-max) 54.5 (26.0–69.0) 57.0 (31.0–78.0) 0.437&
Median duration of HD, month 
(min-max)
53.5 (33.0–131.0) 63.0 (35.0–135.0) 0.353&
*Chi-squared test, &Mann–Whitney U-test, ^Independent t-test
Table 1: Baseline characteristics
Characteristics Frequency (n=69)
Sex, n (%)
Men 35 (50.7%)
Women 34 (49.3%)
Age, median (min-max), years old 55 (26–78)
Comorbid disease, n (%)
Hypertension
Diabetes mellitus
53 (76.8%)
16 (23.2%)
Duration of HD, median (min-max), months 60 (33-135)
BMI, median (min-max), kg/m2 23.6 (16.7-42.6)
BMI categories, n (%)
Type 2 obesity
Type 1 obesity
Pre-obesity
Overweight
Normal
Underweight
2 (1.4%)
5 (3.6%)
18 (13%)
14 (10.1%)
26 (18.8%)
4 (2.9%)
Calcium levels (Ca), median (min-max), mg/dL 9.8 (8.0–10.9)
Phosphate levels (P), mean (± SD), mg/dL 5.5 (0.63)
KLOTHO gene -395 polymorphisms, n (%)
AA genotype
GA genotype
GG genotype
3 (4.3%)
30 (43.5%)
36 (52.2%)
Carotid ultrasonography interpretation, n (%)
Calcification
No calcification
28 (40.6%)
41 (59.4%)
A bivariate analysis was performed to 
determine the association between the KLOTHO gene 
-395 polymorphisms on the incidence of carotid artery 
calcification. Based on statistical tests, a statistically 
significant association was found between the KLOTHO 
-395 gene polymorphisms and the incidence of carotid 
artery calcification with p = 0,015. Furthermore, groups 
with GA and AA genotypes were known to increase risk 
factors by 4,071 times for carotid artery calcification 
compared to the GG genotype group (p = 0,006; 
CI 95% = 1,464–11.320). The presence of A alleles 
in a person is also known to increase the risk of 
carotid artery calcification by 2,292 times compared to 
individuals with G alleles (p = 0,033; CI 95% = 1,058–
4,963) (Table 3).
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studies where the majority of subjects had comorbid 
hypertension in 53 people (76.8%) and followed by 
diabetes mellitus in 16 people (23.3%). Zhang et al., 
in 2012, conducted a study on the prevalence of CKD 
in China, out of 1185 subjects with a decrease in GFR 
<60 ml/min/1.73 m2, as many as 60.5% of the subjects 
had comorbid hypertension and 19.1% of the subjects 
had comorbid diabetes [17]. Hypertensive nephropathy 
in patients with pathological renal changes is indicated 
by the presence of vascular changes, glomerular 
ischemia, and acute tubular interstitial injury. Increased 
intraglomerular pressure caused by hypertension will 
lead to glomerulosclerosis [18].
Table 4: Risk factors that associated with carotid artery 
calcification (final stage of multivariate analysis)
Risk factors B Wald P* PR CI 95%
KLOTHO gene -395 
polymorphisms GA and AA 
genotype
1.996 9.796 0.002 7.363 2.109-25.704
Diabetes 1.829 5.264 0.022 6.230 1.306-29.731
Hypertension 2.336 7.620 0.006 10.343 1.969-54.337
Constanta −2.479
*Logistic regression test
Genetic and environmental factors are two 
factors that make variations in human phenotypes. When 
the DNA genome sequence on the same chromosomes 
of two individuals is compared, there is substantial 
variation in the order at many points throughout the 
genome. Single-nucleotide polymorphisms (SNPs) 
are a genetic variation that occurs when a single-
nucleotide base changes in genome sequence 
and is inherited, which is the most common form of 
genetic variation. This genetic variation is believed to 
influence the tendency of people to suffer from certain 
diseases [7], [19], [20]. KLOTHO, a gene related to 
the aging process, has been known to have a role in 
atherosclerosis and cardiovascular disease. KLOTHO 
mRNA is mainly expressed in the kidneys (especially 
in the distal tubule) and it has been shown that serum 
KLOTHO levels begin to decrease in mild CKD patients 
(stage ≤ 2) and this decrease occurs before the onset of 
increased serum fibroblast growth factor-23 (FGF23), 
parathyroid hormone (PTH), and phosphate [21], [22]. 
KLOTHO expression in humans can vary with single-
nucleotide polymorphisms (SNPs). Several studies 
have identified polymorphisms in KLOTHO and are 
associated with various phenotypes. Recent research 
has focused on G-395A polymorphisms in the KLOTHO 
promoter area [6], [20].
From the results of the KLOTHO gene -395 
polymorphism, we found that the majority of research 
subjects had GG genotype as many as 36 people 
(52.2%) followed by GA genotype as many as 30 
people (43.5%) and AA genotype as many as 3 people 
(4,3%). This finding was consistent with a study of 478 
HD patients in Korea which conducted by Ko et al., in 
2013. They found that the majority of research subjects 
had KLOTHO gene -395 polymorphisms with GG 
genotype as many as 302 people (63.2%) followed by 
GA genotype as many as 158 people (33%) and AA 
genotype as many as 18 people (3.8%) [6]. Nazarian 
et al., in Iran, with 60 HD patients and 60 patients 
control group found that the majority of HD patients had 
KLOTHO gene -395 polymorphism of GG genotype as 
many as 42 people (70%) [8].
Existing studies show the important role 
of KLOTHO in vascular calcification. The G395A 
polymorphism in the KLOTHO gene promoter region 
modifies bone mineral density, which appears to be 
related to atherosclerosis and arterial calcification, both 
of which have the potential to influence coronary heart 
disease [20]. Endothelial dysfunction is a systemic 
pathological condition caused by an imbalance 
between vasorelaxation and vasoconstriction of blood 
vessels. Nitric oxide is a vasodilator that is oxidized by 
acetylcholine and is a major endogenous vasodilator. 
Several studies have shown that KLOTHO can 
induce NO production, the expression of mitochondria 
superoxide dismutase (MnSOD), and suppression 
of NADPH oxidase to protect from oxidative stress 
or show an anti-inflammatory action in protecting 
endothelium [19], [23], [24], [25]. In animal subjects, 
namely, mutant rats or mice performed by nephrectomy, 
it can be seen the acceleration of the development 
of atherosclerosis due to the effects of this gene in 
production of NO [26]. Furthermore, KLOTHO deficiency 
in mice produces increase phosphate and calcium 
levels, hypervitaminosis D, arteriosclerosis, and ectopic 
calcifications including vascular calcification [25]. 
KLOTHO interacts with the FGF23 receptor to take 
sodium-dependent type IIa phosphate transporters 
from the proximal renal tubular cell membrane, which 
causes phosphaturia. The effect of KLOTHO on urinary 
phosphate excretion may contribute to its inhibitory 
effect of ectopic calcification [24], [25].
This study shows that there is a significant 
relationship between the KLOTHO gene -395 
polymorphisms and the incidence of carotid artery 
calcification with p = 0,015, where patients with the 
GA and AA genotype are 4,071 times more likely to 
develop carotid artery calcification than patients with 
GG genotype (p = 0,006). The KLOTHO gene G-395A 
Table 3: Association between KLOTHO gene -395 polymorphisms with carotid artery calcification
KLOTHO gene -395 
polymorphisms 
Calcification No calcification p value* PR CI 95%
AA
GA
GG
1 (3.6)
18 (64.3)
9 (32.1)
2 (4.9)
12 (29.3)
27 (65.3)
0.015 - -
GA+AA
GG
19 (67.9)
9 (32.1)
14 (34.1)
27 (65.9)
0.006 4.071 1.464–11.320
A allele
G allele
20 (35.7)
36 (64.3)
16 (19.5)
66 (80.5)
0.033 2.292 1.058–4.963
*Chi-squared test
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polymorphisms, which is located in the region of the 
KLOTHO gene promoter, has never been reported to 
be related to the incidence of coronary artery disease 
in Europe. However, in Asian countries, for example, in 
Korea and Japan, the G-395A gene is considered as a 
risk factor for coronary artery disease [27].
In the research of Donate-Correa et al., 
in Spain, the KLOTHO gene -396 polymorphisms 
showed no significant results on the appearance of 
cardiovascular diseases such as vascular calcification. 
However, they found that KLOTHO mRNA expression 
was lower in subjects with coronary artery disease 
and the presence of A allele variant of KLOTHO gene 
G-395A polymorphism was associated with lower 
KLOTHO expression in vascular so the risk of causing 
vascular calcification and coronary artery disease [28]. 
But, studies of Rhee et al in Korea and Imamura 
et al in Japan showed that there was a statistically 
significant association between klotho gene G395A 
polymorphisms with the incidence of coronary artery 
disease and could be an independent risk factor for the 
incidence of coronary artery disease [29], [30].
Ko et al. have shown that the presence of 
A allele carriers from the KLOTHO -395 gene is 
associated with accelerated atherosclerosis manifested 
as coronary artery disease and hypertension [6]. This 
study shows that the presence of KLOTHO -395 gene 
A allele in a person can increase the risk of carotid 
artery calcification by 2,292 times compared to 
individuals with G allele (p = 0,033; CI 95% = 1,058–
4,963). The KLOTHO gene G395A polymorphism has 
been reported to be related in influencing the promoter 
function of the gene, where G/A substitution has an 
effect on KLOTHO expression affecting the bone 
density (A allele forms fewer DNA-protein complexes 
compared to G allele) [31]. Our finding was similar 
to those of Imamura et al., in which A allele carrier 
had a significantly higher incidence of coronary artery 
disease than controls [30].
Many clinical studies have tried to find 
an association between risk factors for coronary 
artery calcification or peripheral arterial calcification. 
Jensky et al., in California, showed that hypertension 
and diabetes had a significant risk of coronary 
atherosclerotic calcification characterized by calcium 
deposits in coronary arteries with p < 0.01 and 
p < 0.01 [32]. In addition to KLOTHO gene -395 
polymorphisms, diabetes and hypertension also have 
an association with risk factors for calcification in this 
study (p = 0,022 and p = 0,006). Diabetes mellitus 
has a risk of increasing the incidence of coronary 
calcification, especially medial calcification, and the 
incidence of diabetic nephropathy increases that risk 
[33]. High blood sugar levels trigger the expression of 
osteoblast and osteocalcin transcription factors, thereby 
triggering calcification of vascular smooth muscle 
cells (VSMC) [34], [35]. Angiotensin renin system in 
hypertension plays an important role in the incidence 
of apoptosis, growth, and differentiation of VSMC, and 
therefore, these changes are likely to play a role in the 
occurrence of vascular calcification. [34], [36].
Conclusion
There was an association between the 
KLOTHO gene G395A polymorphism and carotid artery 
calcification in regular hemodialysis patients and the 
presence of KLOTHO -395 gene A allele can increase 
the risk of carotid artery calcification.
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